Navigation Links
Stuy in NEJM: New therapy prevents heart failure
Date:9/1/2009

Patients who had a cardiac resynchronization device combined with a defibrillator (CRT-D) implanted had a 34 percent reduction in their risk of death or heart failure when compared to patients receiving only an implanted cardiac defibrillator (ICD), according to a landmark study published online today in the New England Journal of Medicine and presented today at the European Society of Cardiology Congress (ESC) in Barcelona, Spain. The overall benefit observed from resynchronization therapy was driven by a 41 percent reduction in heart failure. Women who received CRT-D had an "astonishing" 63 percent reduction in their risk of heart failure.

About one million cardiac patients in the United States die each year from either electrical, heart rhythm disorders that result in sudden cardiac death or from mechanical disorders where the heart's pumping ability is impaired (heart failure), according to the study authors.

In 2002, Arthur Moss, M.D., professor of Medicine at the University of Rochester Medical Center, and the MADIT (Multicenter Automatic Defibrillator Implantation Trial) research group showed that an implanted defibrillator, or ICD, reduced the risk of death by 31 percent in cardiac patients as part of the MADIT-II trial. This therapy was soon approved by the U.S. Food and Drug Administration and became part of professional guidelines from the American Heart Association, the American College of Cardiology and the Heart Rhythm Society. Long-term follow-up studies showed, however, that ICDs were so effective at preventing sudden death that patients lived longer and were subsequently at increased risk for heart failure. This created an urgent need to better address both risks in tandem.

Cardiac resynchronization therapy (CRT) is currently approved for treatment only for patients with symptoms of severe heart failure (New York Heart Association [NYHA] class III and IV) in whom it reduces symptoms by improving the mechanic
'/>"/>

Contact: Greg Williams
Greg_Williams@urmc.rochester.edu
585-273-1757
University of Rochester Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. NEJM: Low-fat diets not best for weight loss: New study by Ben-Gurion U. of the Negev
2. Promise of nanodiamonds for safer gene therapy
3. Chemotherapy Linked to Sleep-Wake Cycle Disruptions
4. U.S. Compression Therapy Market to Reach $1.16 Billion in 2015, Finds Frost & Sullivan
5. The benefits of reperfusion therapy
6. Chemotherapy for breast cancer is associated with disruption of sleep-wake rhythm in women
7. CPF Submits Comments to CMS to Save Only Effective Therapy Available to PF Patients
8. Secca(R) Therapy - An Effective and Minimally Invasive Option for Treating Bowel Incontinence - Launched in the US
9. Varian Medical Systems Adds RapidArc(R) and Image Guidance to New Low Energy Treatment Platform for Radiation Therapy in International Cancer Clinics
10. Researchers find high-dose therapy for liver disease not effective
11. NIH grant advances Tay-Sachs disease gene therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... The performance of the Lotteries ... five years. Industry revenue is estimated to grow at ... years through 2014-15, following stabilised growth over the past ... from alternate forms of gambling. Horse and sports betting, ... have all become increasingly popular over the past five ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 The American ... of a Free-Tuition Guarantee for its ICD-10 Medical Coding ... bring the highest level of confidence to students who ... medical coder, but are faced with the uncertainty brought ... implementation of ICD-10 until October 1st, 2015. , AHDPG’s ...
(Date:9/2/2014)... HealthDay Reporter , MONDAY, Sept. 1, ... birth weight are at risk later in life of having ... risk for heart disease, according to a pair of new ... lifetime disadvantages, researchers in both studies -- published online Sept. ... can be overcome. Education appeared to negate the potential ...
(Date:9/2/2014)... 02, 2014 The Jerry Segal Classic ... on September 19 at The ACE Club and Green ... past 25 years, the Classic, organized by the Friends ... for programs and services designed to support patients and ... , “The Segal Classic is a labor of ...
(Date:9/2/2014)... Washington, New York (PRWEB) September 02, 2014 ... LLP announces that Class Counsel has filed ... for service awards in the class action litigation ... Parker Waichman LLP, the Court-Appointed Class Counsel in ... Heimann & Bernstein, LLP; Audet & Partners, LLP; ...
Breaking Medicine News(10 mins):Health News:Lotteries in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Lotteries in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:American Healthcare Documentation Professionals Group (AHDPG) Launches Free-Tuition Guarantee for Its ICD-10 Medical Coding Bridge Program 2Health News:American Healthcare Documentation Professionals Group (AHDPG) Launches Free-Tuition Guarantee for Its ICD-10 Medical Coding Bridge Program 3Health News:Preterm or Small Birth Tied to Long-Term Risks to Heart, Brain 2Health News:Preterm or Small Birth Tied to Long-Term Risks to Heart, Brain 3Health News:The 25th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:A Proposed Order Has Been Submitted in A Class Action Law Suit Brought Over Flushmate Toilets, Parker Waichman Announces 2Health News:A Proposed Order Has Been Submitted in A Class Action Law Suit Brought Over Flushmate Toilets, Parker Waichman Announces 3
... 15, 2007, Philadelphia, PA Researchers found that mesalamine ... with a decrease in incidence of colorectal cancer when ... at the 72nd Annual Scientific Meeting of the American ... Detroit matched 16 patients with ulcerative colitis and Crohns ...
... 2007 Post-hoc and other analyses of secondary endpoints ... plc,s (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) ulcerative colitis ... in patients with mild to moderate ulcerative colitis. These ... open-label 12-14 month extension study, are being presented this ...
... toothbrush may be the,ultimate plaque fighting tool, but it ... Sonicare and GfK Roper reveals that more than half,(54 ... fell on,the bathroom floor, despite voting the bathroom as ... percent). In addition, nine percent of men,admitted to reusing ...
... Strengthen Strategic Consulting ... Canada, MOUNTAIN VIEW, Calif., Oct. 15 ... of software,strategic consulting, and regulatory services for optimizing ... scientific consulting,services practices with three new hires. Pharsight ...
... total sleep times, both habitually and on the morning after ... higher than objectively measured sleep times, according to a study ... Clinical Sleep Medicine (JCSM). , Graciela E. Silva, PhD, of ... were 40 years of age or older. The participants ...
... October 15 Sanofi Pasteur, the,vaccines division ... Institut Pasteur to develop a vaccine against ... have access to antigens,identified by Institut Pasteur ... the most deadly malaria infections. Sanofi Pasteur,intends ...
Cached Medicine News:Health News:Mesalamine linked to cancer protection for high risk inflammatory bowel disease patients 2Health News:New Analyses of long-term LIALDA (mesalamine) data presented at ACG 2Health News:New Analyses of long-term LIALDA (mesalamine) data presented at ACG 3Health News:New Analyses of long-term LIALDA (mesalamine) data presented at ACG 4Health News:New Survey Uncovers Dirty Little Secrets About America's Oral Care Habits 2Health News:New Survey Uncovers Dirty Little Secrets About America's Oral Care Habits 3Health News:Pharsight Expands Global Consulting Services Teams 2Health News:Pharsight Expands Global Consulting Services Teams 3Health News:People overestimate their self-reported sleep times compared to measures by a sleep test 2Health News:Sanofi Pasteur and Institut Pasteur Team up Against Malaria 2Health News:Sanofi Pasteur and Institut Pasteur Team up Against Malaria 3
(Date:9/2/2014)... and ,S-HERTOGENBOSCH, the Netherlands ... http://www.healthlinkeurope.com ) has expanded its North American operations through ... facility, providing warehousing, fulfillment and order to cash services ... , utilizing our global ERP platform. ... serving our customers in Europe ...
(Date:9/2/2014)... Sept. 2, 2014  PANTHERx Specialty Pharmacy announced ... Accreditation from URAC, a Washington, DC ... quality standards for the health care industry. ... The URAC accreditation process demonstrates a commitment ... to improve business processes through benchmarking organizations against ...
(Date:9/2/2014)... 2, 2014  Cyberonics, Inc. (NASDAQ: ... clinical study.  Results of the study presented by ... European cardiology congress and concurrently published by the ... Regulation Therapy (ART) in patients with moderate to ... is safe, improves the heart,s ability to pump ...
Breaking Medicine Technology:HealthLink Europe opens North American medical warehouse operation 2PANTHERx Specialty Pharmacy Applying for URAC Specialty Pharmacy Accreditation 2ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 2ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 3ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 4ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 5
... The dual lumen ... a 1.2 mm inner ... ,Dual oval lumen catheters ... while maintaining maximum catheter ...
The mid-sized titanium port is about 3/4 the diameter and half the weight of the standard model. The silicone catheter has an I.D. of 1.0 mm....
The WaveMap provides immediate clinical decision making information with automatic calculation of pressure gradients and FFR measurements.,SmartWire Pressure Guide Wire - The intelligent choice in ...
... Used for vascular access. ... facilitates single wall puncture with ... sideport is visualized while maintaining ... Sideport exits the hub of ...
Medicine Products: